|
ZNF561 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.372600E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.961400E-04 |
| Normal-vs-Stage2 |
2.852400E-02 |
| Normal-vs-Stage3 |
4.164400E-03 |
| Normal-vs-Stage4 |
3.616300E-02 |
| Stage1-vs-Stage2 |
6.082200E-01 |
| Stage1-vs-Stage3 |
8.837400E-01 |
| Stage1-vs-Stage4 |
9.866000E-01 |
| Stage2-vs-Stage3 |
6.298200E-01 |
| Stage2-vs-Stage4 |
7.835800E-01 |
| Stage3-vs-Stage4 |
9.294800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.843100E-04 |
| Normal-vs-AfricanAmerican |
1.716640E-03 |
| Normal-vs-Asian |
3.060200E-01 |
| Caucasian-vs-AfricanAmerican |
5.761200E-01 |
| Caucasian-vs-Asian |
6.795200E-01 |
| AfricanAmerican-vs-Asian |
4.957000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.9246999999929E-05 |
| Normal-vs-Female |
1.525220E-01 |
| Male-vs-Female |
6.897600E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.981900E-03 |
| Normal-vs-Extreme_Weight |
6.29119999999705E-05 |
| Normal-vs-Obese |
2.364400E-02 |
| Normal-vs-Extreme_Obese |
2.039100E-03 |
| Normal_Weight-vs-Extreme_Weight |
3.709600E-01 |
| Normal_Weight-vs-Obese |
4.798600E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.245400E-01 |
| Extreme_Weight-vs-Obese |
7.481800E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.632200E-01 |
| Obese-vs-Extreme_Obese |
2.519000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.310600E-01 |
| Normal-vs-Age(41-60Yrs) |
9.143000E-03 |
| Normal-vs-Age(61-80Yrs) |
1.607150E-04 |
| Normal-vs-Age(81-100Yrs) |
4.95079999995873E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.691400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.649390E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.139700E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.013200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.021580E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.587980E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.560800E-04 |
| Normal-VS-Type2 PRCC |
3.83270000003932E-06 |
| Normal-VS-KIRP CIMP |
3.352400E-02 |
| Normal-VS-Unclassified PRCC |
2.209000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
9.364000E-02 |
| Type1 PRCC-VS-KIRP CIMP |
8.313800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.337010E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.150400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.027900E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
3.560800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.77639999996171E-06 |
| Normal-vs-N1 |
1.574780E-01 |
| Normal-vs-N2 |
2.63260000465948E-08 |
| N0-vs-N1 |
1.462550E-01 |
| N0-vs-N2 |
4.692000E-02 |
| N1-vs-N2 |
1.774480E-02 |
|
|
